Corporate Wellbeing ROI: How to Measure Whether Employee Mental Health Support Is Working
Measure corporate wellbeing ROI using baselines, validated outcomes, absence, presenteeism, retention and costs, with a worked example and clear cautions.
Germain Gulevic
11/21/202611 min read
Corporate Wellbeing ROI
Corporate wellbeing ROI is measured by comparing the full cost of a programme with the financial value of changes that can plausibly be attributed to it, while reporting employee wellbeing, accessibility and working-condition outcomes alongside that estimate. Utilisation alone cannot demonstrate value, and a favourable before-and-after comparison cannot by itself prove that mental health support caused the change.
A credible evaluation therefore begins before the programme launches, uses validated measures alongside organisational data, and explains the assumptions behind every financial estimate. The purpose is not to produce the largest possible ROI figure, but to establish whether the support is helping employees, which outcomes are changing, and whether the investment should be continued, adapted or replaced.
Why headline ROI figures are not an evaluation
Published ROI figures can support the case for investing in workplace mental health, but they cannot predict what a particular programme will achieve in a particular organisation. Deloitte’s 2024 analysis estimated that poor mental health costs UK employers £51 billion annually and that employers receive an average of approximately £4.70 back for every £1 invested in workforce mental health. That average was informed by a survey of 3,156 working adults and a literature review of 26 sources, rather than by following one organisation through a single intervention, so it should not be treated as a guaranteed benchmark.
More recent economic modelling reinforces the need for organisational specificity. In an April 2026 study published in PLOS Mental Health, Watts and colleagues found that workplace mental wellbeing interventions could be cost-saving in some hypothetical scenarios but not in others, with results varying according to baseline absence, presenteeism, turnover, intervention costs and assumed effectiveness. The authors also noted substantial uncertainty in the underlying inputs and cautioned that their scenarios could not be generalised across workplaces.
The practical implication is that an employer cannot procure a wellbeing platform, apply an industry-average multiplier to its cost and present the result as evidence of organisational value. My existing guide to evidence-based corporate wellness solutions examines the types of support employers can consider, whereas this guide addresses the subsequent procurement question: how should you evaluate whether that support is working in your own setting?
Start with a theory of change, not a dashboard
The first step in evaluating corporate wellbeing ROI is to define which decision the evaluation needs to inform, because a programme intended to improve confidential access to therapy should not be assessed in exactly the same way as manager training, workload redesign or a peer-support intervention. Before selecting metrics, HR, finance and operational leaders should agree what the intervention is expected to change, through which mechanism, over what period, and what action will follow if the expected change does not occur.
This sequence can be expressed as a simple theory of change: the organisation provides a defined intervention, employees become aware of it and can access it safely, employees or managers develop relevant capabilities or resources, working experiences or psychological outcomes improve, and some of those improvements may subsequently influence absence, functioning, retention or productivity. Each stage requires different evidence, because a breakdown in access cannot be diagnosed by measuring absence alone.
The theory of change should also distinguish organisational interventions from individual support. The NICE guideline on mental wellbeing at work recommends organisational-level approaches as the foundation, followed by individual and targeted approaches, and explicitly advises that individual interventions should not replace strategies for reducing work-related stressors. If manager training is intended to reduce unclear priorities, excessive urgency or unsafe team communication, for example, those behaviours and team experiences should be measured directly rather than assuming that counselling uptake will reveal whether leadership has improved. Our guide to stress contagion in teams examines these leadership mechanisms in greater depth.
Establish the baseline and total cost before the programme begins
A wellbeing programme cannot be evaluated credibly without a baseline, because post-intervention results become difficult to interpret when there is no consistent record of what preceded them. Before launch, the evaluation team should document the eligible population, the existing support pathway, relevant working conditions, current awareness and uptake, and a suitable comparison period for organisational outcomes such as sickness absence and turnover. Where seasonal patterns are relevant, comparing equivalent periods or examining a longer time series will usually be more informative than comparing the month before launch with the month afterwards.
The baseline should include employee outcomes as well as HR data. NICE recommends monitoring and evaluating workplace support at least annually and using a validated measure of mental wellbeing, such as the Warwick–Edinburgh Mental Wellbeing Scales or the What Works Wellbeing workplace wellbeing questionnaire. Annual review provides a useful governance minimum, but an intervention may also require an early implementation review and a later follow-up so that access problems can be corrected before an annual report is produced.
Full programme costs need to be established at the same stage, including supplier fees, implementation and technology costs, communication, administration, employee time spent attending sessions, managerial time, and any cover required while employees participate. Omitting internal time can make an intervention appear considerably more efficient than it is, while including only the initial procurement cost can distort comparisons with alternatives that require different organisational resources.
Separate reach, employee outcomes and organisational value
Utilisation measures whether support is being accessed, but it does not demonstrate whether employees benefited or whether the organisation achieved a financial return. High utilisation may indicate accessible and trusted support, although it can also reflect substantial unmet need, while low utilisation may indicate low demand, poor awareness, inconvenient delivery, confidentiality concerns or a mismatch between the intervention and employees’ actual difficulties. Neither figure has a stable meaning without context.
A more informative implementation assessment examines how many eligible employees know about the service, how many can access it, how long they wait, whether they complete the intervention, and whether access differs by role, contract type, working pattern or seniority. Confidential qualitative feedback can help explain why employees chose not to participate, which is particularly important when the people facing the greatest barriers are least visible in provider dashboards.
My 2025 mixed-methods research illustrates why these access questions matter. Among 72 high-stress professionals across six sectors, 69.4% expressed a preference for support delivered independently of their employer. Because this was a modest cross-sector sample measuring preferences rather than programme outcomes, it does not prove that independent provision produces superior ROI, but it does suggest that employers should investigate confidentiality, autonomy and perceived career risk when interpreting uptake. These dynamics are explored further in our article on why professionals may avoid employer-led mental health support.
Employee outcomes should then be assessed separately from reach, using a validated wellbeing measure alongside relevant indicators such as work-related stress, functioning, recovery, psychological safety or confidence in managing specific demands. The selected measures should follow from the programme’s theory of change rather than from whatever data a supplier happens to collect, and results should be reported in aggregated form without turning confidential therapeutic information into an employer monitoring tool.
Organisational outcomes form a third layer, encompassing sickness absence, presenteeism, retention, engagement, team functioning and, where meaningful measurement is possible, productivity. These outcomes often change over different timescales, so an early improvement in access or wellbeing should not be presented as evidence of reduced annual turnover, just as stable absence figures during the first few months should not automatically be interpreted as programme failure.
Treat presenteeism and turnover estimates cautiously
Presenteeism refers to working at reduced capacity because of ill health or reduced wellbeing, and it can represent a substantial organisational cost even though employees remain visible and apparently productive. It is also considerably harder to monetise than sickness absence, because organisations need to estimate both the degree of reduced capacity and the economic value of that reduction without assuming that every hour of salary represents an equivalent quantity of lost output.
The Institute for Employment Studies’ work on EAP ROI identifies the estimation of absence costs and productivity losses as two central methodological challenges. A defensible evaluation should therefore use an appropriate validated instrument, document how productivity change is translated into financial value, and avoid counting the same improvement simultaneously as recovered presenteeism, increased output and reduced absence.
Turnover requires similar restraint, because employees leave for reasons including pay, management, career development, restructuring, health, caring responsibilities and relocation. A wellbeing programme may contribute to retention without being the primary explanation for a change in turnover, so organisations should not multiply every avoided departure by an estimated recruitment cost and attribute the full amount to the intervention. Where attribution is uncertain, it is more credible to report retention as an associated organisational outcome rather than converting it immediately into a financial benefit.
Calculate financial ROI transparently
Financial ROI compares monetised benefits with the total cost of delivering the programme, but the calculation is meaningful only when the organisation discloses which benefits have been included, how those benefits were valued and what proportion of the observed change the intervention is assumed to have caused. One common convention expresses net ROI as a percentage:
ROI(%)=total programme costsmonetised benefits−total programme costs×100
Consider a purely hypothetical programme with a total annual cost of £12,000, including supplier and internal delivery costs. After reviewing the evidence, HR and finance agree that £9,000 of avoided sickness-absence cost and £8,000 of reduced presenteeism can be included under their stated attribution assumptions, while turnover is excluded because its relationship with the intervention is too uncertain. Monetised benefits therefore total £17,000, producing a net benefit of £5,000 and an estimated net ROI of 41.7%.
This example illustrates the arithmetic rather than providing a benchmark, and its result depends entirely on the assumptions entered into it. If only half of the estimated benefits remained defensible under a more conservative scenario, the programme would represent a £3,500 net cost rather than a £5,000 net benefit. Reporting a small range of conservative, central and more favourable scenarios is consequently more informative than presenting one precisely formatted figure whose apparent accuracy exceeds the quality of the underlying evidence.
Because published sources do not all distinguish gross benefits, net benefits and percentage ROI in the same way, every report should state its formula and avoid describing results in terms that cannot be compared directly. The objective is an auditable estimate that another colleague can reconstruct, not a headline figure that depends on hidden conventions.
Why before-and-after comparisons cannot establish causation
A before-and-after evaluation can show that outcomes changed during the period in which a programme operated, but it cannot establish that the programme caused those changes. Sickness absence may also be influenced by seasonal illness, staffing levels, restructuring or changes in absence policy, while wellbeing scores may be affected by workload, leadership changes, economic pressures and events outside work.
Selection effects create a further complication, because employees who choose to use support may differ systematically from those who do not. Comparing participants with non-participants can therefore reflect differences in need, motivation, seniority or existing difficulties rather than the effect of the intervention itself, and organisations that launch support after a particularly difficult period may also observe improvement as conditions naturally return towards their previous baseline.
Where practical, a phased rollout or a suitably matched comparison group can strengthen interpretation without withholding support indefinitely, particularly when everyone eventually receives the intervention. Longer time series can also help distinguish a sustained shift from a short-term fluctuation. When stronger designs are not feasible, the report should use appropriately limited language such as “outcomes improved following implementation” or “the change was associated with the evaluation period,” rather than claiming that the programme generated a precise quantity of savings.
Include professional isolation in the evaluation
Conventional wellbeing dashboards can overlook professional isolation because employees may continue delivering while becoming less connected, less willing to disclose difficulty and less able to access genuinely supportive relationships. This is central to The Isolation Paradox, which explains why high-performing professionals can appear functional while privately carrying an increasing psychological load.
An organisation that measures only attendance and short-term output may therefore miss deterioration in precisely the population whose competence conceals their distress. Depending on the intervention, evaluation should also consider whether employees have a safe place to speak honestly, whether support feels sufficiently independent and confidential, whether managers respond constructively to disclosure, and whether the programme strengthens or weakens meaningful connection.
These outcomes should not automatically be converted into financial values, because their importance does not depend on an immediate monetary return. The research and methodological limitations behind this relational perspective are examined in The Hidden Cost of Professional Isolation, which provides a deeper basis for including connection and psychological safety within programme evaluation.
Measure possible harms as well as benefits
A wellbeing intervention can produce costs or adverse effects that a conventional ROI calculation misses, particularly when training is added to an already excessive workload, when employees feel pressured to disclose personal information, or when digital monitoring weakens trust in an otherwise confidential service. The 2026 PLOS Mental Health model specifically cautions that an intervention could appear cost-saving while negatively affecting employee wellbeing, which is why economic modelling should be considered alongside employee outcomes and feedback rather than used as the sole decision criterion.
The evaluation should consequently ask whether participation created additional time pressure, whether any groups faced reduced access, whether confidentiality was understood and experienced as credible, and whether employees felt able to decline without penalty. NICE’s recommendation that individual approaches should not be used mainly to increase productivity offers an important ethical boundary here: financial value can inform commissioning decisions, but employees should not become instruments through which an organisation pursues productivity while leaving harmful working conditions unchanged.
Where CBT and independent support fit
CBT can form part of a workplace mental health offer when employees want structured support with specific psychological patterns, and NICE includes CBT among the options that should be available to employees seeking further help. Its collaborative goals and regular progress reviews can support outcome measurement, although those goals should concern the individual’s wellbeing and functioning rather than a predetermined employer target for absence or productivity. Our guide to CBT for workplace stress and anxiety explains the approach and its appropriate scope in greater detail.
When therapy is commissioned, employers should agree in advance what aggregated outcome information can be reported and how confidentiality will be protected, while avoiding small-group reporting that could allow individuals to be identified. For professionals who prefer support outside their workplace, I also offer confidential one-to-one CBT independently of employers, although individual therapy should be understood as complementary to organisational change rather than as a method of helping people tolerate unreasonable conditions indefinitely.
What a credible board report should contain
A credible corporate wellbeing report should identify the intervention and eligible population, explain the evaluation period and baseline, report reach and employee outcomes alongside organisational indicators, disclose total costs and monetised benefits, and set out the attribution assumptions and limitations behind any ROI estimate. It should also record non-monetised value, possible harms, employee feedback and the decision that follows, because evaluation is useful only when it changes what the organisation does next.
A positive ROI does not by itself make a programme ethically or clinically successful, just as an uncertain or negative financial result does not automatically mean that support has no value. The strongest report allows leaders to see where the programme is helping, where access or implementation is failing, which conclusions remain uncertain, and whether the next investment should strengthen the current offer, address working conditions directly or test a different approach.
Frequently asked questions
What is a good ROI for corporate wellbeing?
There is no universal ROI figure that every corporate wellbeing programme should achieve, because returns vary with the intervention, workforce, baseline need, delivery quality, evaluation period and costing method. Published averages such as Deloitte’s £4.70 estimate can inform a business case, but an organisation’s own transparent and conservative evaluation is more relevant than matching an external headline figure.
How long does it take to measure corporate wellbeing ROI?
Accessibility, awareness and employee experience can often be assessed during the early implementation period, whereas validated wellbeing outcomes require appropriate baseline and follow-up measurements, and absence or turnover usually need a longer observation window. NICE recommends evaluation at least annually, but organisations should review implementation earlier so that access difficulties are not allowed to persist for a year.
Can wellbeing value be evaluated when financial data are limited?
Organisations with limited financial data can still conduct a useful cost-consequence evaluation by reporting programme costs alongside wellbeing, access, absence, retention and employee-feedback outcomes without converting every outcome into money. This approach preserves uncertainty rather than manufacturing financial precision, and it provides a stronger foundation for later economic analysis as data quality improves.
Conclusion: measure value without overstating certainty
Corporate wellbeing ROI is most useful when it forms one part of a broader evaluation rather than serving as a promise made before the evidence exists. A rigorous approach establishes a baseline, examines whether employees can genuinely access support, measures wellbeing and working conditions alongside organisational outcomes, calculates costs and benefits transparently, and acknowledges that observed change does not automatically establish causation.
If you want to explore why conventional wellbeing programmes often miss professional isolation, and how structured psychological skills can be combined with meaningful connection, The Isolation Paradox develops the underlying research and offers a practical framework for professionals and those designing support. Its central proposition is particularly relevant to evaluation: sustainable recovery depends not only on helping individuals cope, but also on ensuring that they no longer have to carry the entire load alone.